These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2573811)

  • 1. The imidazoline-preferring receptor.
    Lehmann J; Koenig-Bérard E; Vitou P
    Life Sci; 1989; 45(18):1609-15. PubMed ID: 2573811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptors.
    Coupry I; Lachaud V; Podevin RA; Koenig E; Parini A
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):468-70. PubMed ID: 2569318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
    Zonnenchein R; Diamant S; Atlas D
    Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of nonadrenergic [3H]rilmenidine binding in rat brain and kidney.
    King PR; Suzuki S; Louis WJ; Gundlach AL
    Ann N Y Acad Sci; 1995 Jul; 763():194-207. PubMed ID: 7677331
    [No Abstract]   [Full Text] [Related]  

  • 6. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
    Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selectivity of alpha 2-adrenergic agonists for the imidazoline-guanidine and alpha 2-adrenergic receptors].
    Lachaud V; Coupry I; Podevin RA; Koenig E; Parini A
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1135-7. PubMed ID: 2573323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular studies of alpha-2-adrenoceptor and catecholamine-insensitive imidazoline-receptor binding sites using [3H]-rilmenidine in rat brain and kidney.
    King PR; Suzuki S; Nero TL; Gundlach AL; Louis WJ
    J Hypertens Suppl; 1993 Dec; 11(5):S160-1. PubMed ID: 7908962
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
    Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
    Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rilmenidine selectivity for imidazoline receptors in human brain.
    Bricca G; Dontenwill M; Molines A; Feldman J; Tibirica E; Belcourt A; Bousquet P
    Eur J Pharmacol; 1989 Apr; 163(2-3):373-7. PubMed ID: 2566507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]cirazoline as a tool for the characterization of imidazoline sites.
    Angel I; Le Rouzic M; Pimoule C; Graham D; Arbilla S
    Ann N Y Acad Sci; 1995 Jul; 763():112-24. PubMed ID: 7677320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha(2A)-adrenergic versus imidazoline receptor controversy in rilmenidine's action: alpha(2A)-antagonism in humans versus alpha(2A)-agonism in rabbits.
    Molderings GJ; Bonisch H; Bruss M; Gothert M
    Ann N Y Acad Sci; 2003 Dec; 1009():279-82. PubMed ID: 15028600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.